作者: Jingwu Duan , Bin Jiang
DOI:
关键词:
摘要: Non-steroidal compounds are provided which useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity including obesity, diabetes, inflammatory and immune diseases, have structure formula (I) or an enantiomer, a diastereomer, pharmaceutically acceptable salt, hydrate thereof, where J is selected from NR1 C(R4)(R4a); K NR2 C(R5)(R5a); L NR3 C(R6)(R6a); A, X, Y, R1, R2, R3, R4, R4a, R5, R5a, R6, R6a, R8, R10, R11, n defined herein. Also pharmaceutical compositions methods diabetes comprising said compounds.